Related Experiment Video
Updated: Nov 1, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Appendiceal pseudomyxoma peritonei: predictors of recurrence and iterative surgery
Joseph C Kong1,2,3, Michael P Flood1,2,3, Glen R Guerra1,2,3,4
1Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Aim:
Appendiceal pseudomyxoma peritonei (PMP) is a rare entity, with recurrence rates up to 26% despite optimal cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Evidence specific to PMP originating from non-infiltrative appendiceal mucinous neoplasms (low grade - LAMN and high grade - HAMN) is lacking. The aim of this study was to identify patterns of recurrence and predictive factors for patients appropriate for iterative surgery.
Method:
A bi-institutional retrospective analysis was performed on patients undergoing complete cytoreduction and HIPEC for PMP derived from perforated LAMN or HAMN. Multivariate logistic regression was performed to identify independent predictors for re-do CRS. Five-year overall survival (OS) was stratified according to surgical intervention, and 5-year disease-free survival (DFS) was stratified according to histological PMP grade. Cox regression analysis was performed to identify independent predictors for OS and DFS.
Results:
Sixty of 239 (25.1%) patients developed peritoneal recurrence between 2007 and 2020. The median time to recurrence was 20.7 months. The risk of disease recurrence was highest with high-grade PMP (P <0.001) and increasing PCI (P <0.001). Patients with high-grade histology from their index procedure and aged over 60 years were less likely to be offered iterative surgery on multivariate analysis. Patients who underwent iterative CRS and HIPEC had a 5-year survival of 100%.
Conclusion:
Iterative CRS and HIPEC is feasible in selected patients with recurrent PMP, displaying good oncological outcomes. Age, index histology and level of abdominal quadrant involvement are predictive of proceeding to re-do surgery.
Insights
Recurrent appendiceal pseudomyxoma peritonei (PMP) can be treated with repeat cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC), offering good outcomes in selected patients. Age and tumor grade predict eligibility for this iterative surgery.
Area of Science:
- Oncology
- Surgical Oncology
- Gastroenterology
Background:
- Appendiceal pseudomyxoma peritonei (PMP) has a significant recurrence rate (26%) even after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).
- Limited data exists on recurrence patterns and predictors for PMP specifically arising from non-infiltrative appendiceal mucinous neoplasms (LAMN and HAMN).
Purpose of the Study:
- To identify recurrence patterns in patients with PMP originating from LAMN or HAMN.
- To determine predictive factors for selecting patients suitable for iterative CRS and HIPEC.
Main Methods:
- A bi-institutional retrospective analysis of patients with PMP from perforated LAMN or HAMN who underwent complete CRS and HIPEC.
- Multivariate logistic and Cox regression analyses were used to identify predictors for re-do CRS, overall survival (OS), and disease-free survival (DFS).
Main Results:
- Peritoneal recurrence occurred in 25.1% of patients, with a median time to recurrence of 20.7 months.
- High-grade PMP and higher Peritoneal Cancer Index (PCI) were associated with increased recurrence risk.
- Patients over 60 years old and with high-grade index histology were less likely to be offered iterative surgery.
- Iterative CRS and HIPEC resulted in 100% 5-year survival.
Conclusions:
- Iterative CRS and HIPEC is a viable treatment for selected recurrent PMP patients, yielding favorable oncological outcomes.
- Patient age, initial tumor histology, and the extent of abdominal involvement predict suitability for repeat surgery.
More Related Videos
Related Concept Videos
Appendicitis-II: Diagnostic Studies and Management
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
Appendicitis-I: Introduction
Etiology: Appendicitis can arise from various causes, primarily rooted in the obstruction of the appendix lumen. Factors contributing to this obstruction include fecal accumulation, lymphoid hyperplasia and, in...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:

